💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Rossari Biotech Limited is an India-based company. The Company is engaged in the manufacturing, selling and distribution of specialty chemicals. Its products cater to global brands in the Fast Moving Consumer Goods (FMCG) sector and find applications in a host of consumer…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, steadily growing business, trading cheap versus its own history.
Rossari Biotech is scored on the general / industrial framework. It keeps a slim 6.2% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT 0.44×) — worth a closer look. Free cash flow is worth about -6.5% of its market value.
Over the last 3 years revenue compounded at 13%/yr and profit at 12%/yr. Book value has grown 13%/yr. Return on equity is a modest 10.8%. In the latest quarter profit grew 11% versus the prior quarter.
At 16× earnings, the stock sits at the 2nd percentile of its own 3.6-year range — the cheap end of where it has historically traded. Today's price implies ~5%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 15.51 | — | — |
| P/B | 1.68 | 2.66 | better |
| EV/EBITDA | 7.71 | 9.95 | better |
| ROE | 10.85 | — | — |
| ROCE | 13.37 | 70.06 | worse |
| ROA | 6.47 | — | — |
| Quick Ratio | 1.05 | 2.26 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 59.1 | 14.3 | 23.9% |
| SRF | 32.3 | 4.8 | 14.9% |
| Linde India | 118.3 | 13.3 | 11.3% |
Revenue has grown every year across all 4 financial years shown. 13% CAGR over 3 years — steady double-digit compounder.
Net profit has risen every year — the hallmark of a compounder.
Operating margins have been stable around 8% — no major structural shift.
ROE at 11% — modest; the capital isn't working hard. Low variance across years — a predictable business that earns steadily on its equity base.
EPS has grown every year — each share earns more than the last, consistently. 11% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 0.4× PAT — reported profit isn't translating into cash, raising earnings quality questions. Investing outflows exceed operating cash — the company relies on external funding to finance expansion.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Run-rate stepping up — recent quarters average 9% above earlier ones.
Profit jumped 11% QoQ — check if this is operating leverage or a one-off item.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold 68.1% — heavily owner-operated with strong skin in the game. MF stake down 4.4pp — domestic funds are booking profits or rebalancing out.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.